ZNF703

ZNF703
Identifiers
AliasesZNF703, ZEPPO1, ZNF503L, ZPO1, NLZ1, zinc finger protein 703
External IDsOMIM: 617045; MGI: 2662729; HomoloGene: 81391; GeneCards: ZNF703; OMA:ZNF703 - orthologs
Orthologs
SpeciesHumanMouse
Entrez

80139

353310

Ensembl

ENSG00000183779

ENSMUSG00000085795

UniProt

Q9H7S9

P0CL69

RefSeq (mRNA)

NM_025069

NM_001101502
NM_001110508

RefSeq (protein)

NP_079345

NP_001094972
NP_001103978

Location (UCSC)Chr 8: 37.7 – 37.7 MbChr 8: 27.47 – 27.47 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse
zinc finger protein 703
Identifiers
SymbolZNF703
NCBI gene80139
HGNC25883
RefSeqNM_025069
Other data
LocusChr. 8 p12

ZNF703 is a gene which has been linked with the development of breast cancers. ZNF703 is contained within the NET/N1z family responsible for regulation of transcription essential for developmental growth especially in the hindbrain. Normal functions performed by ZNF703 include adhesion, movement and proliferation of cells. ZNF703 directly accumulates histone deacetylases at gene promoter regions but does not bind to functional DNA.

Following research by scientists at Cancer Research UK, it was the first oncogene discovery in the past six years.

ZNF703 is a part of 8p12 telomeric amplicon that is associated with Luminal B breast cancer. Recently, ZNF703 is identified as the driver of 8p12 locus amplification.

Patients diagnosed with luminal B cancer caused by ZNF703 typically have lower recovery and survival rates than other cancer types.

Drug resistance of ZNF703 has been displayed when patients are treated using anti-cancer drug Tamoxifen.